Tonix Pharmaceuticals Holding (TNXP) Inventory Average (2023 - 2026)

Tonix Pharmaceuticals Holding's Inventory Average history runs 4 years deep, the most recent figure standing at $2.3 million for Q1 2026.

• On a quarterly basis, Inventory Average fell 71.92% year-over-year to $2.3 million in Q1 2026; TTM through Mar 2026 was $2.3 million, a 71.92% decrease from a year earlier, with the FY2025 full-year figure at $4.7 million, up 5.52% from the prior year.
• Inventory Average retreated to $2.3 million in Q1 2026 per TNXP's latest filing, from $3.4 million in the prior quarter.
• Across five years, Inventory Average topped out at $13.5 million in Q3 2023 and bottomed at $2.3 million in Q1 2026.
• The 4-year median for Inventory Average is $6.4 million (2024), against an average of $6.7 million.
• Across the five-year window, Inventory Average rose 28.66% in 2025 and plunged 71.92% in 2026, its largest moves.
• Year by year, Inventory Average stood at $6.9 million in 2023, then sank by 36.83% to $4.4 million in 2024, then dropped by 23.07% to $3.4 million in 2025, then sank by 30.97% to $2.3 million in 2026.
• Per Business Quant, the three latest TNXP Inventory Average figures stand at $2.3 million (Q1 2026), $3.4 million (Q4 2025), and $5.9 million (Q3 2025).